OrbiMed’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-526,600
Closed -$3.59M 152
2021
Q4
$3.59M Buy
526,600
+232,600
+79% +$1.59M 0.05% 142
2021
Q3
$3.41M Buy
294,000
+105,296
+56% +$1.22M 0.04% 160
2021
Q2
$3.22M Buy
+188,704
New +$3.22M 0.03% 151
2021
Q1
Sell
-400,400
Closed -$8.26M 168
2020
Q4
$8.26M Hold
400,400
0.07% 126
2020
Q3
$10.5M Buy
+400,400
New +$10.5M 0.13% 107